Duquesne Family Office (Druckenmiller) — TEVA Trade History
Quarter-by-quarter changes in the Teva Pharmaceutical Inds Ltd position · CUSIP 881624209
Currently held · 2 YearsFirst seen: 2024 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 624,999 | -1,752,286 | -73.7% | $21.2K | 0.41% |
| 2026 Q1 | 2026-05-15 | Reduce | 2,377,285 | -3,497,585 | -59.5% | $71.6K | 2.12% |
| 2025 Q4 | 2026-02-17 | Reduce | 5,874,870 | -10,719,065 | -64.6% | $183.4K | 4.08% |
| 2025 Q3 | 2025-11-14 | Add | 16,593,935 | 625,000 | +3.9% | $335.2K | 8.25% |
| 2025 Q2 | 2025-08-15 | Add | 15,968,935 | 1,089,185 | +7.3% | $267.6K | 6.57% |
| 2025 Q1 | 2025-05-15 | Add | 14,879,750 | 5,882,350 | +65.4% | $228.7K | 7.47% |
| 2024 Q4 | 2025-02-14 | Add | 8,997,400 | 7,569,450 | +530.1% | $198.3K | 5.33% |
| 2024 Q3 | 2024-11-14 | New | 1,427,950 | 1,427,950 | — | $25.7K | 0.87% |
| 2024 Q2 | 2024-08-14 | — | — | — | — | — | — |
| 2024 Q1 | 2024-05-15 | — | — | — | — | — | — |
| 2023 Q4 | 2024-02-14 | — | — | — | — | — | — |
| 2023 Q3 | 2023-11-14 | — | — | — | — | — | — |
| 2023 Q2 | 2023-08-14 | — | — | — | — | — | — |
| 2023 Q1 | 2023-05-15 | — | — | — | — | — | — |
| 2022 Q4 | 2023-02-14 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-14 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-15 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-16 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-14 | — | — | — | — | — | — |
| 2021 Q1 | 2021-11-17 | — | — | — | — | — | — |
| 2021 Q2 | 2021-11-17 | — | — | — | — | — | — |
| 2021 Q3 | 2021-11-15 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-16 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-16 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-14 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-15 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-14 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-14 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-14 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-15 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-14 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.